A previous study has demonstrated that CCL2 produced by tumor and stromal cells in the TME can promote the recruitment of monocytes to the TME and the polarization of TAMs towards the pro-tumoral M2 type [18]. The gene discussed is CCL2; the disease is neoplasm.